Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2020 | Pulmobiotics | Seed Round | 2.2M |
7/2020 | OneChain Immunotherapeutics | Seed Round | 3.6M |
9/2022 | Atekka | Venture Round | 4.9M |
12/2020 | Telomere Therapeutics | Seed Round | 1.8M |
5/2023 | ARTHEx Biotech | Series B | 0 |
12/2021 | Integra Therapeutics | Seed Round | 0 |
3/2021 | MiiMOSA | Venture Round | 8.9M |
12/2021 | Corteria Pharmaceuticals | Seed Round | 0 |
7/2020 | Telum Therapeutics | Seed Round | 4.7M |
1/2020 | ARTHEx Biotech | Seed Round | 1.7M |
5/2020 | Gyala Therapeutics | Seed Round | 1.6M |
5/2021 | Telomere Therapeutics | Venture Round | 2.3M |
7/2020 | ARTHEx Biotech | Seed Round | 5M |
6/2023 | OneChain Immunotherapeutics | Seed Round | 7.4M |
6/2023 | OneChain Immunotherapeutics | Seed Round | 0 |
5/2023 | ARTHEx Biotech | Series B | 0 |
9/2022 | Atekka | Venture Round | 0 |
12/2021 | Corteria Pharmaceuticals | Seed Round | 0 |
12/2021 | Integra Therapeutics | Seed Round | 0 |
5/2021 | Telomere Therapeutics | Venture Round | 0 |
3/2021 | MiiMOSA | Venture Round | 0 |
12/2020 | Telomere Therapeutics | Seed Round | 0 |
7/2020 | OneChain Immunotherapeutics | Seed Round | 0 |
7/2020 | ARTHEx Biotech | Seed Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|